Bemiparin versus unfractionated heparin as bridging therapy in the perioperative management of patients on vitamin K antagonists: the BERTA study. - Wikidata - awgldk - TriplyDB

Bemiparin versus unfractionated heparin as bridging therapy in the perioperative management of patients on vitamin K antagonists: the BERTA study.

Bemiparin versus unfractionated heparin as bridging therapy in the perioperative management of patients on vitamin K antagonists: the BERTA study.

http://www.wikidata.org/entity/Q33410944

about

Unfractionated heparin versus low molecular weight heparins for avoiding heparin-induced thrombocytopenia in postoperative patients.

P2860

Q33441234-3139172E-D053-4657-9F42-69A43F4BEE98

P2860

Bemiparin versus unfractionated heparin as bridging therapy in the perioperative management of patients on vitamin K antagonists: the BERTA study.

http://www.wikidata.org/entity/Q33410944

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Bemiparin versus unfractionate ...... antagonists: the BERTA study.

@ast

Bemiparin versus unfractionate ...... antagonists: the BERTA study.

@en

type

label

Bemiparin versus unfractionate ...... antagonists: the BERTA study.

@ast

Bemiparin versus unfractionate ...... antagonists: the BERTA study.

@en

prefLabel

Bemiparin versus unfractionate ...... antagonists: the BERTA study.

@ast

Bemiparin versus unfractionate ...... antagonists: the BERTA study.

@en

P1433

Q33410944-6C12F729-99BB-44A0-AC20-A21724042BDE

P1476

Q33410944-7609845F-928A-47FF-AE2D-6EBC59DF0349

P2093

Q33410944-2758E7D3-4360-4D5D-AE94-E4AEDC3FB547

Q33410944-2B694B1B-E233-4ABC-835D-F4904577DAA0

Q33410944-310409D2-04D1-450F-A8B0-6CAE24273757

Q33410944-52DF7435-87B1-47B0-94BC-E62EEBD185D3

Q33410944-55D9CBB4-7B1E-4533-A152-DA02E7EFD5DF

Q33410944-77CC8756-9C9D-4EFD-AF7B-7A8FC0267156

Q33410944-786D9F5D-3F21-477F-898A-0B8499A699EA

Q33410944-842C7F2B-D0DA-44E4-98D5-F4B7FF16383F

Q33410944-904D7657-D3C0-481B-8F1B-FE1C33BD6CCF

Q33410944-A60C5126-F495-4095-A014-1C9E9C975D8F

P2860

Q33410944-0AC48E2D-A27F-4319-9FB8-C65B207808F3

Q33410944-19D30667-5122-486F-A809-E47DCC1D0C73

Q33410944-1C987157-D000-41A5-97F3-1C6112DDCE2E

Q33410944-23F6DE06-34D0-413A-BBD3-32378E229781

Q33410944-2D68FEAD-3195-4891-B274-5E1A670F0AAF

Q33410944-2FD11095-DB44-4632-AB49-722A4B4E8B09

Q33410944-30C05286-6AF2-4BE9-9C5B-3881B7F9BC4C

Q33410944-3856DA55-F330-4C04-B85B-65FD7564AE4D

Q33410944-40E5B175-9C2A-45D1-9340-BF196A87E26B

Q33410944-5281E7BE-F120-4A6E-9E04-7DDA0AC19723

P304

Q33410944-6E8D9B98-9B91-405E-A499-CC1A588C2DAF

P31

Q33410944-A1F3B0EC-C43E-425F-94D7-BBA2D82F6A28

P356

Q33410944-FFD5C1E2-2ADF-489A-9268-ED55B64407BC

P433

Q33410944-D4608931-73B7-41BE-950F-B611D3A9B9E8

P478

Q33410944-75A94085-6726-409C-8B8F-5F798CE296FD

P50

Q33410944-987DA979-43A9-4DCB-9AFE-9862D807A5B6

P577

Q33410944-F1BE066B-FE19-4C2D-9B0C-4D2ADB6DB308

P698

Q33410944-FC3C36A8-69E9-4B5C-8638-A96F2CF9CF05

P921

Q33410944-df3dca11-bb4a-4088-b12a-d2c2c73b3322

P356

S40261-013-0141-6

P1433

Clinical Drug Investigation

P1476

Bemiparin versus unfractionate ...... antagonists: the BERTA study.

@en

P2093

Amparo Santamaría

http://www.w3.org/2001/XMLSchema#string

Arantxa Ugarriza

http://www.w3.org/2001/XMLSchema#string

Carmen Benet

http://www.w3.org/2001/XMLSchema#string

Carmen Muñoz

http://www.w3.org/2001/XMLSchema#string

Elena Pina

http://www.w3.org/2001/XMLSchema#string

Francisca López-Chulia

http://www.w3.org/2001/XMLSchema#string

Franciso Javier Roncalés

http://www.w3.org/2001/XMLSchema#string

Isabel De Diego

http://www.w3.org/2001/XMLSchema#string

Javier Martínez-González

http://www.w3.org/2001/XMLSchema#string

Jordi Fontcuberta

http://www.w3.org/2001/XMLSchema#string

P2860

Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin

CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials

Perioperative management of patients receiving oral anticoagulants: a systematic review.

Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Perioperative management of oral anticoagulation: when and how to bridge.

Periprocedural antithrombotic management: a review of the literature and practical approach for the hospitalist physician.

Periprocedural bridging anticoagulation: current perspectives.

New challenges for a second-generation low-molecular-weight heparin: focus on bemiparin.

Bridging therapy and oral anticoagulation: current and future prospects.

Update in bridging anticoagulation.

P304

921-928

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40261-013-0141-6

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24127170

http://www.w3.org/2001/XMLSchema#string

P921